for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CVS Health Corp

CVS

Latest Trade

66.16USD

Change

-0.34(-0.51%)

Volume

6,250,665

Today's Range

65.73

 - 

66.46

52 Week Range

51.72

 - 

82.15

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
66.50
Open
66.32
Volume
6,250,665
3M AVG Volume
159.16
Today's High
66.46
Today's Low
65.73
52 Week High
82.15
52 Week Low
51.72
Shares Out (MIL)
1,300.50
Market Cap (MIL)
86,040.86
Forward P/E
9.48
Dividend (Yield %)
3.02

Next Event

Dividend For CVS.N - 0.5000 USD

Latest Developments

More

CVS Health Sets Quarterly Dividend Of $0.50 Per Share

CVS Pharmacy Announced Collaboration With Google Photos On Their New Same-Day, Print-To-Store Experience

CVS Health Says Seeing Additional Traffic And Sales Due To "HealthHUBs" - Conf. call

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About CVS Health Corp

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Industry

Healthcare Facilities

Contact Info

1 Cvs Dr

+1.401.7651500

https://www.cvshealth.com/

Executive Leadership

David W. Dorman

Independent Chairman of the Board

Larry J. Merlo

President, Chief Executive Officer, Director

Eva C. Boratto

Chief Financial Officer, Executive Vice President

Jonathan C. Roberts

Chief Operating Officer, Executive Vice President

Lisa G. Bisaccia

Chief Human Resource Officer, Executive Vice President

Key Stats

2.14 mean rating - 28 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

177.5K

2017

184.8K

2018

194.6K

2019(E)

252.6K
EPS (USD)

2016

5.840

2017

5.900

2018

7.080

2019(E)

6.977
Price To Earnings (TTM)
19.06
Price To Sales (TTM)
0.38
Price To Book (MRQ)
1.40
Price To Cash Flow (TTM)
10.99
Total Debt To Equity (MRQ)
116.32
LT Debt To Equity (MRQ)
109.23
Return on Investment (TTM)
3.12
Return on Equity (TTM)
2.40

Latest News

Latest News

RPT-FOCUS-CVS drug coverage plan based on outside pricing review is off to a slow start

A CVS Health Corp health plan that uses an outside drug pricing group to help it decide whether to cover certain new medicines has gained little traction with customers, according to its top medical executive, and has drawn fierce criticism from patient advocacy groups.

CVS drug coverage plan based on outside pricing review is off to a slow start

A CVS Health Corp <CVS.N> health plan that uses an outside drug pricing group to help it decide whether to cover certain new medicines has gained little traction with customers, according to its top medical executive, and has drawn fierce criticism from patient advocacy...

CVS suspends sales of Zantac brand and generic heartburn drug during safety review

CVS Health Corp said on Saturday it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products by the U.S. Food and Drug Administration.

U.S. pension insurer, CVS tapped for Purdue creditors' committee

Two of Purdue Pharma's biggest creditors, the Pension Benefit Guaranty Corp and CVS Health, will help represent unsecured creditors in the recently launched bankruptcy of the Oxycontin maker.

U.S. judge approves CVS purchase of insurer Aetna

A federal judge reviewing a Justice Department decision to allow U.S. pharmacy chain and benefits manager CVS Health Corp <CVS.N> to merge with health insurer Aetna said on Wednesday that the agreement was in fact legal under antitrust law.

U.S. judge approves CVS purchase of insurer Aetna

A federal judge reviewing a Justice Department decision to allow U.S. pharmacy chain and benefits manager CVS Health Corp to merge with insurer Aetna said on Wednesday that the agreement was legal under antitrust law.

CVS fights ex-exec's appellate bid to join Amazon's PillPack

CVS Health is urging a federal appeals court to uphold a ban on a former company executive from working at an Amazon.com Inc online pharmacy subsidiary that aims to disrupt the healthcare industry.

CVS Health raises 2019 profit forecast after beating profit estimates

CVS Health Corp <CVS.N> raised its full-year profit forecast and reported higher-than-expected second-quarter results on Wednesday, as increased U.S. prescription drug prices fueled rebates to its pharmacy benefits business.

CVS Health posts second-quarter profit on Aetna strength

CVS Health Corp on Wednesday reported a profit for the second quarter compared with a year-ago loss, benefiting from its Aetna health insurance acquisition and higher sales of prescription drugs.

Ex-CVS exec appeals injunction against working for Amazon's PillPack

A former CVS Health executive has urged a federal appeals court to hold that a non-compete agreement he signed with the company that has prevented him from working at Amazon.com Inc's PillPack online retail pharmacy is "excessively broad" and unenforceable.

CVS enters home dialysis care with clinical trial of new system

CVS Health said on Wednesday it will start a clinical trial of its new home dialysis system this week, setting it up to compete directly with the two largest operators of U.S. dialysis centers, Fresenius Medical Care AG and DaVita Inc.

Ex-CVS exec blocked from working for Amazon's PillPack seeks quick appeal

A former CVS Health executive is urging a federal appeals court to quickly review a judge's decision that blocks him from working at Amazon.com Inc's PillPack online retail pharmacy due to a noncompete clause, saying it's causing him "undue financial and personal hardship."

Former CVS exec can't work for Amazon's PillPack, judge rules

A federal judge on Tuesday blocked a former CVS Health executive from working at Amazon.com Inc's PillPack online pharmacy unit, saying that allowing him to take a job where he would help drive its "disruptive strategy" would violate a non-compete agreement.

CVS must face generic drug overcharging class action - 9th Circuit

A federal appeals court on Wednesday revived a class action lawsuit accusing pharmacy chain CVS Health Corp of systematically overcharging people who bought generic drugs using insurance rather than cash.

Plucky inventor sues Walmart, Target, CVS over brow razor patent

A California inventor of a personal styling razor has sued Target Corp, Walmart Stores and CVS Pharmacy for patent infringement, accusing them of selling knockoffs of her patented product in their stores.

CVS to expand health hubs to 1,500 stores by end of 2021

CVS Health Corp said it would offer expanded health services such as nutrition counseling and blood pressure screenings in 1,500 stores by the end of 2021, following through on plans announced during the pharmacy chain's 2018 acquisition of health insurer Aetna.

CVS to expand health hubs to 1,500 stores by end of 2021

CVS Health Corp said it will offer expanded health services such as nutrition counseling and blood pressure screenings in 1,500 stores by the end of 2021, following through on plans announced during the pharmacy chain's 2018 acquisition of health insurer Aetna.

U.S. judge calls hearing on merger of CVS and Aetna: court filing

A federal judge on Monday ordered up to three days of hearings next month to consider CVS Health Corp's $69 billion merger with Aetna, which has closed but must still get court approval.

McKesson meets full-year profit estimates, renews partnership with CVS

U.S. drug distributor McKesson Corp forecast a full-year profit on Wednesday that matched analysts' estimates, easing some fears over drug pricing pressures and costs of opioid-related litigations.

CVS Health raises full-year profit forecast on Aetna strength

CVS Health Corp on Wednesday raised its full-year profit forecast and reported first-quarter earnings that topped Wall Street estimates due to growth in its Aetna health insurance business, and as drug prices fell within its expectations.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up